Introduction
The increasing interest to reduce perinatal morbimortality rates has stimulated the search for adequate and effective methods for assessing fetal growth and wellbeing in high risk pregnancies. Several biochemical, biophysical and clinical methods have been suggested to allow a better evaluation of the fetus. Good fetal vitality will result in a vigorous neonate with an adequate birthweight. This will depend on good placental function, normal fetal growth and the presence or absence of fetal distress. With the aim of obtaining reliable fetal growth indicators, the following determinations have been performed: 1. Human chorionic somatomammotropic hör-mone (hCS) which reflects the trophoblast endocrine functions [24] and may play a role in fetal growth [26] . 2. Estriol, synthetized by the feto-placental unit [5] , the levels of which reflect fetal adrenal and placental functions and the metäbolic exchange between fetal and placental compartments. 3. Oxytocinase. The maternal levels of this enzyme, produced by the sincitiotrophoblast, may reflect functional placental mass [13] .
Material and Methods
A group of 56 women with high risk pregnancies were studiedsincethe 32nd week of gestation. The associated maternal diseases are shown in Tab. I. The cases with arterial hypertension were those with diastolic blood pressure of 90 mm Hg or higher. Diabetic patients were classified according toWHITE [30] .
Curriculum vitae
When patients were Rh (-) and had a positive agglutinin title they were considered Rh isoimmunization.
In the group of other diseases were included patients with cardiac disease, urinary infection, intrauterine growth retardation and epilepsy. Serum hCS, estriol and Oxytocinase levels were compared among the different maternal groups. The variance analysis did not show statistical differences between these diseases. Oxytocinase activity was determined by a colorimetric method, using L-cystine-di-B-naftilamide äs Substrate [29] . All newborns were weighed using the same scale and during the first hour of life. Gestational age was calculated by weeks of amenorrhea and confirmed by the score of CAPURRO [2] . Newborns were considered small for date when their weight was below the lOth percentile of the local growth curve [3] (Fig. 1) . The newborns were classified into two groups, small for date and adequate weight for gestational age. The mean gestational agejn the small for date group was 268 ± 13.7 days (X ± l SD) and in the adequate weight group, 274.3 ± 14.4 days (X ± l SD). The difference between both groups was not statistically significant (t test).
Results

hCS, estriol and oxytocinase levels related with birihweight.
The mean level of hCS obtained during the week preceding delivery was correlated with the weight of the newborns. There was a weak association between both variables (r = 030, p <0.05) ( A weak correlation was found (r = 0.33, p < 0.01) (Fig. 3 ). Oxytocinase levels were determined only in 42 patients. The correlation between these levels and birthweight was weak (r = 0.30, p < 0.05) (Fig. 4) . 
hCS, estriol and Oxytocinase levels according to birthweight (small for date and adequate weight).
hCS. Maternal hCS level corresponding to 42 newborns with adequate birthweight for their gestational age was 7.94 ± 3.98 ug/ml (X ± l SD). This value was statistically higher (t test, p < 0.05) than the corresponding to the group of 14 small for date newborns, which was 5.15 ± 2.11 ug/ml (X± l SD) (Fig. 5 ). Based on this difference, a critical level of 7 ug/ml was arbitrarily established. In 12 of 33 pregnancies (36.4%) with levels of 7 ug/ml or less of hCS in serum, newborns were small for their gestational age.
On the other hand, when serum hCS level was higher than 7 ug/ml, only 2 of 23 newborns (8.7%) were small for date. The difference between both groups was statistically significant (FISHER test, p = 0.015) (Fig. 6 ).
Estriol. The mean value of maternal estriol in serum was compared between 37 adequate weight newborns (42.38 ± 18.55 ng/ml) and 14 small for dates (29.24 ± 16.75 ng/ml). A statistically significant difference was found between both groups (t test, p < 0.05) (Fig. 7 ).
•p<0.05 date. On the other hand, when the serum estriol level was more than 35 ng/ml, only 5 of 28 neonates (17.9%) were small for dates. This difference was not statistica y significant BIRTH WEIGHT FOR (F HER test, p = 0.06) (Fig. 8) .
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Oxytocinase. A similar analysis between both groups of adequate weight and small for date neonates was performed with the mean level of Oxytocinase. There was no statistically significant difference (t test, p > 0.05). However, oxytocinase levels were higher in the group of mothers with adequate weight newborns (7.10 ± 2.53 mg B-naftflamide/100 ml/hr) than in the group of mothers with small for date neonates (5.74 ± 2.41 mg B-naft amide/100 ml/hr). Critical hCS and serum estriol levels were considered jointly (7 ug/ml and 35 ng/ml respectively). Neonates were divided into two groups: One group from mothers with both hormones below the critical levels, and the other from mothers in whom both values were above this level.
In the group of mothers with levels below the critical value, 8 of 13 neonates (615%) were small n. 23 O Fig. 7 . Mean maternal estriol values obtained the week before delivery for both groups, small-for-date and adequate weight neonates.
Based on this difference, the arbitrary value of 35 ng/ml was established s critical level for serum estriol. In 9 of 23 pregnancies (39.1%) with serum estriol of 35 ng/ml or less, the newborns were small for 0. for date; on the other hand, when hormone levels were above the critical level, only l of the 13 newborns (7.7%) was small for date. The difference between both groups was statistically significant (FISHER test, p = 0.005). In 26 mothers in whom both hormone levels were above or below criticalvalues, the correct prediction of adequate weight or small for date was made in 20 (76.9%) (Fig. 9) . From the total number of 51 patients studied, 26 (51%) had both hCS and estriol levels either above or below critical values. In 10 patients (19.6%) hCS was above and estriol was below 
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Fisher p-0.005 Fig. 9 , Neonate distribution according to the birthweight for gestational age when critical levels of both hormone s were considered concomitantly. n· 13 critical values. In 15 pregnancies (29.4%) the reverse Situation was found (Fig. 10 ).
Discussion
Several authors have found an association between birth-weight and matemal serum levels of hCS, estriol and oxytocinase [l, 8, 10, 11, 12, 14, 15, 16, 17, 18, 20, 21, 22, 23, 25, 28] . However, this association was not confirmed by others [4, 6, 7, 19, 27] . Although we have found statistically significant correlations between these Parameters in our population, their dispersion was considerable. When we divided our newborns into two groups, one of small for dates and the other with adequate birthweight, maternal serum levels of hCS and estriol were significantly lower in those with small for date newborns. On the other hand, there was no statistically significant difference when only oxytocinase serum levels were studied. A critical level of maternal serum hCS and estriol was established according to the above results, below which newborns would have a greater possibility of being small for date. Approximately 30% of the newborns with maternal hCS serum levels equal or lower than 7 ug/ml were small for date. A similar incidence of small for dates was observed when maternal serum estriol levels were lower than 35 ng/n . However, a greater proportion of false negatives (18%) (small for dates with high hormonal levels) was observed with estriol than with hCS, whose incidence of false negatives was 8.7%. When both hormones were considered simultaneously, in 50% of the patients, both levels were either high or low. The prediction of birthweight was correct in 77% of these cases (Fig. 9) . Only one of these 26 pregnant women (3.8%) had a small for date newborn and higher than critical matemal hormone levels. r Summarizing, our results indicate that fetal growth can be better predicted by the concomitant consideration of hCS and estriol levels in matemal serum than by studying each hormone separately.
Summary
A group of 56 women with high risk pregnancies were studied since the 32nd week of gestation. With the aim of obtaining reliable fetal growth indicators, maternal serum hCS, estriol and oxytocinase levels were determined. hCS and estriol were determined by specific radioimmunoassays and oxytocinase with a colorimetric ipethod. Meän values obtained the week before delivery öf both hormones and the enzyme were correlated with the weight of the newborns. The correlation coefficients were 0.30, 0.33 and 030 for hCS, estriol and oxytocinase respectively (Figs.2,3and4) . The newborns were classified into two groups, small for date and adequate weight for gestational age. Maternal hCS level corresponding to newborns with adequate birthweight for their gestational age was 7.94 ug/ml. This value was statistically higher than that corresponding to the group of smäll-for-date newborns, which was 5.15 ug/ml (Fig. 5) . Similar results were obtained when the maternal estriol levels were considered according to the birthweight (Fig.  7) . The same analysis applied to oxytocinase values did not show statistically significant differences. Arbitrary critical levels were estäblished for hCS and estriol at 7 ug/ml and 35 ng/ml respectively. When values were below these levels, newborns would have greater possibility of being small for dates (Figs. 6 and 8) . The predictive value was best when both hormones were considered concomitantly (77%) (Fig. 9) . These results indicate the suitability of considering hCS and estriol levels in order to assess fetal growth.
Keywords: Adequate-weight newborn, fetal growth, high risk pregnancies, serum estriol, serum hCS, serum oxytocinase, small-for-date newborn. fig. 7) . Par contre, la meme analyse appliquee a Foxy tocinase n'a pas revele de differences statistiquement significatives. Des degres critiques arbitraires ont ete fixes respectivement pour la SCh et Festriol ä 7 Mg/ml et 35 Mg/ml. S'üs sont inferieurs % a ces seuils, on observe une plus grande probabilite d'immaturite pour les nouveaux-nes ( fig. 6 et 8) .
Le pronostic est le plus precis en cas d'evaluation simultanee de ces deux hormones (77%) (fig. 9 ). On peut donc recommander la mesure de la SCh et de Festriol si on veut de terminer Fevolution de la croissance foetale.
Mots-cles: Croissance foetale, estriol du serum, grossesses a haut risque, nouveaux-nes de poids normal, nouveaux-nes immatures, oxytocinase du serum, SCh.
